High volume image-guided injections and structured rehabilitation improve greater trochanter pain syndrome in the short and medium term: a combined retrospective and prospective case series (±27.6) mm at the final time point, a mean of 60 weeks (p<0.01). The Hip and Groin Outcome Score in the prospective group showed a non-significant increase from 173.2 to 296.1 (p=0.12). Conclusion: HVIGI&SR should be considered when short-and medium-term pain-relieving treatment for GTPS is required. Controlled studies are warranted to fully establish effectiveness, and assess long term effects. Level of evidence: case series.
Introduction
Of the hip complaints presenting to primary care, 10-20% are thought to be due to greater trochanter area pain 1 . Within the US military an incidence of 2.03 per 1000 person-years was found, with a significantly greater incidence in women compared to men 2 . The causes of trochanteric pain are numerous including trochanteric bursitis, tendinopathy, muscle tears, iliotibial band disorders and bursalin flammation [3] [4] [5] . As a result of this, and the difficulty in making a precise diagnosis, the term Greater Trochanteric Pain Syndrome (GTPS) has been implemented in clinical practice 6 . The majority of patients with GTPS are managed conservatively and respond well to therapies that include progressive exercise and education 6 . Corticosteroid injections are also commonly used as a non-operation option with reported responses ranging from 60-100% 7 . However the literature also suggests that the longevity of the corticosteroid injection effect is limited and is less effective than home training or shock wave therapy 8 . Indeed the site of the corticosteroid injection may be important, as one study suggested that greater trochanteric bursa injections are superior to deep to gluteus medius bursa injections 9 . A recent review suggested that despite its common use in clinical practice there are very few studies on its effectiveness, and also minimal evidence comparing blind injections to image guided injections 7 . Surgery is used in very recalcitrant cases, however the evidence base does not allow definitive conclusions about the best form of treatment for different presentations to be made with confidence 6 . Many people suffer recalcitrant and recurrent problems with significant impact on health 10 ; indeed the effect of greater trochanteric pain syndrome on a patient's life has been found by Fearon et al. to be similar in some respects to late stage hip osteoarthritis 11 .
Summary
Background: the aim of this study was to measure the effects of high volume image-guided injections and structured rehabilitation (HVIGI&SR) for greater trochanter pain syndrome (GTPS). Methods: 31 consecutive subjects were recruited (23 retrospectively; 8 prospectively) over 5 months. GTPS was diagnosed based on history and examination findings, alongside radiological examination. The HVI-GI used a 22-gauge spinal needle to administer 10ml of 0.5% Marcaine and 50 mg hydrocortisone just deep to the periosteum underlying the gluteal tendon insertion under ultrasound guidance, followed by structured rehabilitation. A visual analogue scale (VAS) for pain was used as the main outcome measure. Results: the mean VAS improved from 81.7 mm (±17.6) to 42.3 mm (±28.3), (p<0.05) in the prospective subjects at a mean of 6 weeks, considered clinically significant. In the retrospective subjects the mean VAS had improved from 74.6 (±10.9) mm to 38.2(±31.2) mm at two weeks (p<0.01) and 31. 3 
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Materials and methods
Subjects
Every patient (n=8) attending one specialist MSK radiology clinic over a five month period who met the inclusion and exclusion criteria (Tab. 1) were recruited prospectively, completing a visual analogue scale (VAS) for pain and the Hip and Groin Outcome Score (HAGOS) at the appointment and then again at six weeks post-HVIGI&SR 16 . Retrospective patients (n=23) were identified from a database covering the previous two years and sent the above questionnaires. Ethical clearance was obtained from Queen Mary University of London Ethics of Research Committee and consent was obtained via the questionnaire. The subjects' characteristics can be seen in Table 2 . The research followed the guidelines as laid out by Padulo et al. 17 . Please see Appendix 1 for copies of the questionnaire (both retrospecHigh volume image-guided injections with structured rehabilitation (HVIGI&SR) have been shown to be effective in improving pain and function for both Achilles and patellar tendinopathy [12] [13] [14] . More recently they have been shown to be effective in the short term reduction of pain and improvement in function in shoulder impingement syndrome, another syndrome encompassing many diagnoses 15 . The mechanism behind the effect of the HVI-GI is not well understood but Chan et al. 13 hypothesise that there is disruption of the neovascularisation seen in tendinopathy. In shoulder impingement syndrome, which encompasses other non-tendinopathy conditions. Morton et al. 15 hypothesise that there is disruption of the scar tissue or separation of tissues, although it is recognised that more work is required to confirm this. Therefore, the aim of this research was to provide preliminary evidence to clinicians about the short-and medium-term treatment effectiveness of HVIGI&SR for GTPS, using both retrospective and prospective data. HVIGI&SR for GTPS tive and prospective) and Appendix 2 for a copy of the HAGOS questionnaire.
Procedure
All ultrasound scanning and interventions were carried out by the same skilled MSK radiologist. The injection consisted of 10 ml 0.5% Marcaine and 50 mg hydrocortisone. The area of greatest pain over the greater trochanter was marked. A 22-gauge spinal needle was introduced just deep to the periosteum using an aseptic technique (Fig. 1) . The injection was performed with ultrasound guidance using a 13MHz probe (Elegra; Siemens, Erlangen, Germany), but not real-time guidance.
Structured rehabilitation
Following the injection, the patients were reviewed by a consultant physiotherapist or his deputy, who prescribed a standardised structured rehabilitation programme. Patients were initially advised to have relative rest for 3 days and 400 mg ibuprofen up to three times a day for the first three days as required, if not contraindicated. An exercise programme was developed that met their activity-specific targets. The primary intervention was educational, with advice given to avoid positions that put the gluteal tendons into compressive positions, such as postural advice to avoid lateral slouch standing and excessive adduction postures in sitting 18, 19 . Non-impact cardiovascular exercise was advised if not already undertaken, optimally three times a week with an interval training component if tolerable. Assessment was based on the clinical examination principles outlined by Grimaldi (2011) and Reiman et al. (2014) 20, 21 .The specific exercise element focussed on developing isometric and concentric-eccentric endurance tolerance in weight bearing during the first two weeks of the rehabilitation programme; progressing to increased load tolerance over 4 weeks, with power and impact being included in the programme last and only to the level required for function 19 . Exercises were assessment based, but typically included hip extensor and abductor activation and endurance training alongside core body control exercise that focussed on lateral trunk control, as the hip abductors are recognised to be key in core stabilisation 19 . Adductor or horizontal plane rotation exercises were less commonly prescribed.
Analysis
The change in the VAS pain scale was used to assess pain effects. The HAGOS was used to describe hip-specific functions 16 . Data was analysed using SPSS (SPSS statistics version 20, IBM, USA). The data was found to be normally distributed. A paired ttest was used to analyse both the pre and post-injection VAS and HAGOS scores. Significance was set at p<0.05.
Results
Six of the eight prospective subjects completed the follow-up questionnaire. The mean follow-up time was 43.5 days. In the retrospective study fourteen of the 23 subjects completed the questionnaires, a total response rate of 63% in the retrospective group. Overall the response rate was 65%. The mean time between the injection and completion of the questionnaire in the retrospective group was 60 weeks. Thirty-five per cent of all subjects had experienced pain for over 2 years prior to their attendance for HVIGI&SR.
VAS Pain Scale Results
In the prospective study, the mean VAS scores were reduced from 81.7 mm (±17.6) pre-injection to 42.3 mm (±28.3), a change of 39.4 mm, at a mean time of 43.5 days follow-up (p=0.03), (Fig. 2 ). In the retrospective study, the mean VAS also reduced from 74.6 mm (±10.9) pre-HVIGI&SR to 38.2 (±31.2) mm at 2 weeks, which is both statistically and clinically significant (p<0.01). The overall reduction in the VAS score of the retrospective group was a change of 43.3 mm from 74.6 (±10.9) mm to 31.4 (±27.6) mm at a mean time of 60 weeks (p<0.01), showing a maintained reduction in the VAS score. 62% of retrospective subjects had returned to their normal level of activity at the mean follow up time of 60 weeks. Four out of the 8 prospective subjects reported that they Figure 1 . Insertion of the 22-spinal gauge needle under ultrasound guidance and administration of HVIGI.
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jects all had had their pain for >18 months prior to the injection. None of the prospective subjects had any additional therapy in the time in which they were followed up.
Discussion
Both the retrospective and prospective groups showed a statistically significant reduction in pain following a HVIGI into the periosteum overlying the greater trochanter in patients with GTPS followed by structured rehabilitation. A reduction of 9 mm on the VAS pain scale is considered clinically significant in an acute pain setting and therefore the reduction of 43.3 mm for the retrospective group and 39.4 mm for the prospective group is likely to be considered a good clinical improvement in the presence of chronic symptoms 22 .These findings are also comparable to other treatments used in GTPS, including extracorporeal shock wave therapy 6, 23 . Shbeeb et al. have found that a single local corticosteroid injection resulted in a greater than 60% improvement in the short and medium-term, which is similar to the 62% who had returned to their normal activity level in this study 24 . Rompe et al. showed that a home training regime showed the greatest long term improvement in comparison to corticosteroid injections, although in the short-term corticosteroid injections were most successful 8 . It is therefore likely that the combination of both the HVIGI and the standard rehabilitation programme in this study will ensure patients benefit in the short term from the injection and, in the longer term, from the rehabilitation programme; longer follow up is required to confirm this. The change observed in the HAGOS in the prospective group showed a trend towards significance (p =0.13), likely due to the small group size. There was a statistically significant (p=0.04) improvement in the questions relating to quality of life, which is likely to be clinically important to those receiving any treatment. However, due to the small group size and inter-patient variability, no strong conclusions can be drawn from the HAGOS data, and further confirmation with larger numbers is required. Unlike for patellar and Achilles tendinopathy, the proposed mechanism of effect for the HVIGI is not disruption of neovascularisation, nor is it likely to be disruption of scar tissue as none was visualised on ultrasound 12, 13, 15 . It is however hypothesised that the injectate lifts the periosteum, causing a local reaction which stimulates a healing response. This mechanistic theory requires further study. It has also been hypothesised that the chemical effects of Marcaine may cause some local denervation so that pain is diminished. Further radiological studies such as magnetic resonance imaging, and also surgical examination, may be useful to evaluate the potential mechanism of the injection. Whatever the underlying mechanism it is believed that the rehabilitation programme is required to ensure long term benefit and to decrease the risk of recurrence.
had returned to their normal levels of activity at the mean time of 43.5 days.
Hip and Groin Outcome Score
For the prospective group the mean HAGOS, for the six who completed the follow-up questionnaire, increased from 173.2 (±103.3) pre-HVIGI&SR to 294.4 (±163.2) at follow-up, which was not statistically significant (p= 0.13). The majority of improvement occurred in the quality of life element of the questionnaire, which was statistically significant (p=0.04). The changes for each element are shown in Figure 3 . Twenty five percent (n=5) of all subjects reported short term pain as a side effect of the injection. One subject reported short term stiffness as a result of the injection. No other side effects were described or observed.
Of the fourteen retrospective subjects two went on to have surgery in the time period following their injection and prior to being followed up by this study (one had iliotibial band lengthening, the other unknown); one other subject had acupuncture. Of these sub- It remains unclear as to why some patients have a good response to the HVIGI&SR, while others experience little or no effect. When one is considering HVI-GI&SR, adherence to the rehabilitation programme is likely to be important in the overall outcome, along with other psychosocial factors such as pain beliefs and everyday use of the hip, for example at work. Future studies would therefore benefit from establishing patients' experiences of a HVIGI&SR, especially in comparison to other treatment modalities. Also, GTPS covers so many pathologies that it may be some respond better than others and again this requires further investigation, with other imaging modalities perhaps being useful in assessing which conditions will benefit more from such an injection [3] [4] [5] . One suggestion is to use MRI pre-HVIGI and follow the subsequent changes to soft tissues and the bone on MRI over a suitable follow-up period, to allow clinicians to visualise the effects on the soft tissue and to establish whether certain initial changes seen on MRI predict the responsive to the HVIGI&SR. This would allow the HVIGI&SR to be targeted to those in whom it is likely to be clinically effective. The side effects of pain and stiffness described by the subjects are similar to the findings in a study that used steroid injections in GTPS 8 . With this being a temporary phenomenon and with the lack of any other side effects a HVIGI&SR in GTPS can provisionally be considered safe subject to confirmation in larger cohort controlled studies.
Study Limitations
The main limitation of this study was the size of the study, despite having both the retrospective and prospective data. This is especially noticeable within the prospective group and a longer recruitment period would be beneficial in the future. A sample size calculation using an 80% power and 5% significance suggests a sample size of 16 is required to show significance, 10 more than in this study 25 . It should however be noted that the majority of patients attending the had already failed conservative management, as shown in Table 2 by the number of clinicians patients had seen prior to their injection, and this is likely to affect the ability to recruit patients as it is normally a tertiary referral for the HVIGI&SR. The follow up time of just over six weeks in the prospective group is also not ideal, especially as the majority of the subjects had experienced pain for over two years. However, the retrospective follow-up at 60 weeks appears to show maintenance of the pain relieving effect, with 62% of the retrospective subjects reporting that they had returned to their normal level of activities.This is in contrast to a study which showed that the effect of a local corticosteroid injection alone declined after 1 month 8 , therefore suggesting that the HVIGI&SR combination avoids this decline. Out of the retrospective subjects only three had an additional treatment; 2 underwent surgery and 1 had acupuncture suggesting the majority responded to the HVIGI and physiotherapy rehabilitation alone. It seems therefore likely that the findings in the prospective group would be maintained, although confirmation of this is required. It would also be useful to study whether adherence to the physiotherapy programme improved the outcomes associated with the HVIGI as it is likely that the injection primarily allows a pain-free period in which to start the rehabilitation programme correctly.
Future Research
As described above, further research is required to determine the mechanism of action of the HVIGI&SR in GTPS. More work is also required to establish the duration of the effect of a HVIGI&SR in GTPS. Anecdotally, 8 of the patients had more than one HVIGI. A randomised control trial would be the gold standard to establish the effects of the HVIGI&SR, although in the short term a larger prospective study would be beneficial.
Conclusions
A high volume image guided injection into the periosteum of the greater trochanter followed by a structured physiotherapy-led rehabilitation programme should be considered as an effective treatment in the short and medium term for GTPS, when conservative measures have previously failed. Further controlled studies are warranted to conclusively determine the long-term effects of a HVIGI&SR, along with comparison to other treatment modalities. 
HVIGI&SR for GTPS
Function, sports and recreational activities
The following questions concern your physical function when participating in higher-level activities. Answer every question by ticking the appropriate box. If a question does not pertain to you or you have not experienced it in the past week please make your "best guess" as to which response would be the most accurate. The questions should beanswered considering what degree of difficulty you have experienced during thefollowing activities in the past week due to problems with your hip and/or groin. 
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